Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing
- 23 June 2010
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 53 (4) , 616-623
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Impact of High-Dose Peginterferon Alfa-2A on Virological Response Rates in Patients with Hepatitis C Genotype 1: a Randomized Controlled Trial† ‡Hepatology, 2009
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearanceNature, 2009
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2009
- A Mathematical Model of Hepatitis C Virus Dynamics in Patients With High Baseline Viral Loads or Advanced Liver DiseaseGastroenterology, 2009
- Interferon signaling and treatment outcome in chronic hepatitis CProceedings of the National Academy of Sciences, 2008
- Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trialHepatology, 2007
- Intrahepatic Hepatitis C Virus Replication Correlates with Chronic Hepatitis C Disease Severity In VivoJournal of Virology, 2006
- Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trialJournal of Hepatology, 2004
- Progressive Liver Injury in Chronic Hepatitis C Infection Correlates With Increased Intrahepatic Expression of Th1–Associated CytokinesHepatology, 1996
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996